Q2 EPS Forecast for United Therapeutics Increased by Analyst
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Investment analysts at Leerink Partnrs increased their Q2 2025 earnings estimates for shares of United Therapeutics in a research report issued on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will post earnings of $8.08 per share for the quarter, up […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Investment analysts at Leerink Partnrs increased their Q2 2025 earnings estimates for shares of United Therapeutics in a research report issued on Wednesday, June 4th. Leerink Partnrs analyst R. Ruiz now anticipates that the biotechnology company will post earnings of $8.08 per share for the quarter, up […]
